114 related articles for article (PubMed ID: 38452717)
1. Development and validation of a prognostic model for cervical cancer by combination of machine learning and high-throughput sequencing.
Shi R; Chang L; Shi L; Zhang Z; Zhang L; Li X
Eur J Surg Oncol; 2024 Apr; 50(4):108241. PubMed ID: 38452717
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
[TBL] [Abstract][Full Text] [Related]
3. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
4. Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer.
Li J; Wan C; Li X; Quan C; Li X; Wu X
J Transl Med; 2023 Sep; 21(1):647. PubMed ID: 37735483
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data.
Chai R; Zhao Y; Su Z; Liang W
Front Oncol; 2023; 13():1277084. PubMed ID: 38023180
[TBL] [Abstract][Full Text] [Related]
6. Conduction and validation of a novel prognostic signature in cervical cancer based on the necroptosis characteristic genes via integrating of multiomics data.
Xu T; Jiang J; Xiang X; Jahanshahi H; Zhang Y; Chen X; Li L
Comput Biol Med; 2024 Jan; 168():107656. PubMed ID: 38029530
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
[TBL] [Abstract][Full Text] [Related]
8. A 5-year survival status prognosis of nonmetastatic cervical cancer patients through machine learning algorithms.
Yu W; Lu Y; Shou H; Xu H; Shi L; Geng X; Song T
Cancer Med; 2023 Mar; 12(6):6867-6876. PubMed ID: 36479910
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of single-cell and bulk RNA-seq establishes a novel signature for prediction in gastric cancer.
Wen F; Guan X; Qu HX; Jiang XJ
World J Gastrointest Oncol; 2023 Jul; 15(7):1215-1226. PubMed ID: 37546563
[TBL] [Abstract][Full Text] [Related]
10. Decoding the tumor microenvironment and molecular mechanism: unraveling cervical cancer subpopulations and prognostic signatures through scRNA-Seq and bulk RNA-seq analyses.
Lin Z; Li X; Shi H; Cao R; Zhu L; Dang C; Sheng Y; Fan W; Yang Z; Wu S
Front Immunol; 2024; 15():1351287. PubMed ID: 38482016
[TBL] [Abstract][Full Text] [Related]
11. Single-cell RNA-Seq and bulk RNA-Seq reveal reliable diagnostic and prognostic biomarkers for CRC.
Zhang X; Yang L; Deng Y; Huang Z; Huang H; Wu Y; He B; Hu F
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9805-9821. PubMed ID: 37247080
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of single-cell RNA-seq dataset and bulk RNA-seq dataset constructs a prognostic model for predicting survival in human glioblastoma.
Lai W; Li D; Kuang J; Deng L; Lu Q
Brain Behav; 2022 May; 12(5):e2575. PubMed ID: 35429411
[TBL] [Abstract][Full Text] [Related]
13. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma.
Jiang A; Wang J; Liu N; Zheng X; Li Y; Ma Y; Zheng H; Chen X; Fan C; Zhang R; Fu X; Yao Y
Front Genet; 2022; 13():833797. PubMed ID: 35154287
[No Abstract] [Full Text] [Related]
14. Machine learning based evaluation of clinical and pretreatment
Nakajo M; Jinguji M; Tani A; Yano E; Hoo CK; Hirahara D; Togami S; Kobayashi H; Yoshiura T
Abdom Radiol (NY); 2022 Feb; 47(2):838-847. PubMed ID: 34821963
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
Shu J; Jiang J; Zhao G
Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis-related gene signatures reveal the prognosis of cervical cancer based on single cell sequencing and co-expression network analysis.
Kang J; Xiang X; Chen X; Jiang J; Zhang Y; Li L; Tang J
Front Cell Dev Biol; 2022; 10():1086835. PubMed ID: 36712973
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer prediction with transcriptome profiling using feature selection and machine learning methods.
Taghizadeh E; Heydarheydari S; Saberi A; JafarpoorNesheli S; Rezaeijo SM
BMC Bioinformatics; 2022 Oct; 23(1):410. PubMed ID: 36183055
[TBL] [Abstract][Full Text] [Related]
18. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
[TBL] [Abstract][Full Text] [Related]
19. Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma.
Mi K; Zeng L; Chen Y; Yang S
Int J Gen Med; 2023; 16():5031-5050. PubMed ID: 37942473
[TBL] [Abstract][Full Text] [Related]
20. A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification.
Yang W; An L; Li Y; Qian S
Aging (Albany NY); 2023 Sep; 15(18):9408-9425. PubMed ID: 37768206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
